Epitranscriptome in Ischemic Cardiovascular Disease: Potential Target for Therapies
- 1 June 2022
- journal article
- review article
- Published by Wolters Kluwer Health in Stroke
- Vol. 53 (6) , 2114-2122
Abstract
The global risk of cardiovascular disease, including ischemic disease such as stroke, remains high, and cardiovascular disease is the cause of one-third of all deaths worldwide. The main subjacent cause, atherosclerosis, is not fully understood. To improve early diagnosis and therapeutic strategies, it is crucial to unveil the key molecular mechanisms that lead to atherosclerosis development. The field of epitranscriptomics is blossoming and quickly advancing in fields like cancer research, nevertheless, poorly understood in the context of cardiovascular disease. Epitranscriptomic modifications are shown to regulate the metabolism and function of RNA molecules, which are important for cell functions such as cell proliferation, a key aspect in atherogenesis. As such, epitranscriptomic regulatory mechanisms can serve as novel checkpoints in gene expression during disease development. In this review, we describe examples of the latest research investigating epitranscriptomic modifications, in particular A-to-I editing and the covalent modification N6-methyladenosine and their regulatory proteins, in the context of cardiovascular disease. We additionally discuss the potential of these mechanisms as therapeutic targets and novel treatment options. Download figure Download PowerPointKeywords
This publication has 94 references indexed in Scilit:
- Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferaseCell Research, 2014
- A METTL3–METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylationNature Chemical Biology, 2013
- Epigenetics in clinical practice: the examples of azacitidine and decitabine in myelodysplasia and acute myeloid leukemiaLeukemia, 2013
- ALKBH5 Is a Mammalian RNA Demethylase that Impacts RNA Metabolism and Mouse FertilityMolecular Cell, 2013
- Structure and Function of Noncanonical NucleobasesAngewandte Chemie International Edition, 2012
- Comprehensive Analysis of mRNA Methylation Reveals Enrichment in 3′ UTRs and near Stop CodonsCell, 2012
- Topology of the human and mouse m6A RNA methylomes revealed by m6A-seqNature, 2012
- Genetics of Human Cardiovascular DiseaseCell, 2012
- N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTONature Chemical Biology, 2011
- Deaminase Activity on Single-stranded DNA (ssDNA) Occurs in Vitro when APOBEC3G Cytidine Deaminase Forms Homotetramers and Higher-order ComplexesJournal of Biological Chemistry, 2011